Abstract
Purpose
To evaluate the relationship between serum Anti-Müllerian hormone (AMH) level and body mass index (BMI) in infertile patients.
Methods
Medical records of patients with infertility evaluated between January 2013 and February 2018 in the Reproductive Medicine Department of a private hospital were reviewed. Patients with the following criteria were excluded from the study: polycystic ovary syndrome, primary ovarian insufficiency, AMH values > 10 ng/mL, current oral contraceptive users and previous ovarian surgery or endometriosis, and anovulation of other causes, except decreased ovarian reserve.
Results
A total of 2204 infertile patients were included (mean age 34.58 ± 4.3 years, mean BMI 22.35 ± 3.6 kg/m2, and mean serum AMH 2.44 ± 2.17 ng/ml). In the entire group of patients, serum AMH level was positively correlated with BMI after adjustment for age (beta = 0.059, p < 0.005). When the association between serum AMH level and BMI was analysed in subgroups of patients, after adjustment for age, we found a positive correlation between the two parameters in patients ≤ 35 years old (< 0.05), of normal weight (p < 0.05) and with normal ovarian reserve (p < 0.05). After adjustment for age, BMI ≥ 25 kg/m2 was significantly associated with higher AMH values in comparison to normal weight patients.
Conclusions
In infertile patients, AMH is positively correlated with BMI, especially in patients younger than 35 years, of normal weight and with normal ovarian reserve. Moreover, the presence of mild excess adiposity seems to be associated with higher AMH values. Our data contradict the previous studies showing a negative impact of excess adiposity on AMH serum levels.
Similar content being viewed by others
References
R.L. Cate, R.J. Mattaliano, C. Hession, R. Tizard, N.M. Farber, A. Cheung, E.G. Ninfa, A.Z. Frey, D.J. Gash, E.P. Chow, R.A. Fisher, J.M. Bertonis, G. Torres, B.P. Wallner, K.L. Ramachandran, R.C. Ragin, T.F. Manganaro, D.T. MacLaughlin, P.K. Donahoe, Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell 45, 685–698 (1986)
K.R. Hansen, G.M. Hodnett, N. Knowlton, L.B. Craig, Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil. Steril. 95, 170–175 (2011)
A.Z. Steiner, F.Z. Stanczyk, S. Patel, A. Edelman, Antimullerian hormone and obesity: insights in oral contraceptive users. Contraception 81, 245–248 (2010)
S.L. Broer, B.W. Mol, D. Hendriks, F.J. Broekmans, The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil. Steril. 91, 705–714 (2009)
E.W. Freeman, C.R. Gracia, M.D. Sammel, H. Lin, L.C. Lim, J.F. Strauss, 3rd Association of antimullerian hormone levels with obesity in late reproductive-age women. Fertil. Steril. 87, 101–106 (2007)
H.I. Su, M.D. Sammel, E.W. Freeman, H. Lin, T. DeBlasis, C.R. Gracia, Body size affects measures of ovarian reserve in late reproductive age women. Menopause 15, 857–861 (2008)
M. Olszanecka-Glinianowicz, P. Madej, A. Owczarek, J. Chudek, P. Skalba, Circulating anti- Mullerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome. Clin. Endocrinol. 83, 98–104 (2015)
H.T. Park, G.J. Cho, K.H. Ahn, J.H. Shin, Y.T. Kim, J.Y. Hur, S.H. Kim, K.W. Lee, T. Kim, Association of insulin resistance with anti-Mullerian hormone levels in women without polycystic ovary syndrome (PCOS). Clin. Endocrinol. 72, 26–31 (2010)
S. Sahmay, T. Usta, C.T. Erel, M. Imamoglu, M. Kucuk, N. Atakul, H. Seyisoglu, Is there any correlation between amh and obesity in premenopausal women? Arch. Gynecol. Obstet. 286, 661–665 (2012)
S. Halawaty, E. ElKattan, H. Azab, N. ElGhamry, H. Al-Inany, Effect of obesity on parameters of ovarian reserve in premenopausal women. J. Obstet. Gynaecol. 32, 687–690 (2010)
M. Dolleman, W.M. Verschuren, M.J. Eijkemans, M.E. Dolle, E.H. Jansen, F.J. Broekmans, Y.T. van der Schouw, Reproductive and lifestyle determinants of anti-Mullerian hormone in a large population-based study. J. Clin. Endocrinol. Metab. 98, 2106–2115 (2013)
J. Dupont, M. Reverchon, L. Cloix, P. Froment, C. Ramé, Involvement of adipokines, AMPK, PI3K and the PPAR signaling pathways in ovarian follicle development and cancer. Int. J. Dev. Biol. 56, 959–967 (2012)
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81(1), 19–25 (2004)
A.P. Ferraretti, A. La Marca, B.C.J.M. Fauser, B. Tarlatzis, G. Nargund, L. Gianarolion, on behalf of the ESHRE working group on Poor Ovarian Response Definition: ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Human. Reprod. 26(7), 1616–1624 (2011)
WHO. Physical Status: The Use and Interpretation of Anthropometry. Report of a WHO Expert Committee. (World Health Organization, Geneva, 1995).
M.R. Sowers, D. McConnell, M. Yosef, M.L. Jannausch, S.D. Harlow, J.F. Randolph Jr., Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period. Ann. N.Y. Acad. Sci. 1204, 95–103 (2010)
B.L. Wajchenberg, J.A. Marcondes, M.B. Mathor, S.S. Achando, O.A. Germak, M.A. Kirschner, Free testosterone levels during the menstrual cycle in obese versus normal women. Fertil. Steril. 51, 535–537 (1989)
E. Buyuk, D.B. Seifer, E. Illions, R.V. Grazi, H. Lieman, Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with normal ovarian reserve. Fertil. Steril. 95, 2364–2368 (2011)
L.A. Bernardi, M.R. Carnethon, P.J. de Chavez, D.E. Ikhena, L.M. Neff, D.D. Baird, E.E. Marsh, Relationship between obesity and anti-Müllerian hormone in reproductive-aged African American women. Obesity. 25, 229–235 (2017)
J. Simões-Pereira, J. Nunes, A. Aguiar, S. Sousa, C. Rodrigues, J. Sampaio Matias, C. Calhaz-Jorge, Influence of body mass index in anti-Müllerian hormone levels in 951 non-polycystic ovarian syndrome women followed at a reproductive medicine unit. Endocrine (2018). https://doi.org/10.1007/s12020-018-1555-y.
A. La Marca, E. Spada, V. Grisendi, C. Argento, E. Papaleo, S. Milani, A. Volpe, Normal serum anti-Mullerian hormone levels in the general female population and the relationship with reproductive history. Eur. J. Obstet. Gynecol. Reprod. Biol. 163, 180–184 (2012)
S. Jung, N. Allen, A.A. Arslan, L. Baglietto, L.A. Brinton, B.L. Egleston, R. Falk, R.T. Fortner, K.J. Helzlsouer, A. Idahl, R. Kaaks, E. Lundin, M. Merritt, C. Onland-Moret, S. Rinaldi, M.J. Sanchez, S. Sieri, H. Schock, X.O. Shu, P.M. Sluss, P.N. Staats, R.C. Travis, A. Tjønneland, A. Trichopoulou, S. Tworoger, K. Visvanathan, V. Krogh, E. Weiderpass, Zeleniuch-Jacquotte, W. Zheng, J.F. Dorgan, Demographic, lifestyle, and other factors in relation to antimullerian hormone levels in mostly late premenopausal women. Fertil. Steril. 107, 1012–1022.e2 (2017)
I.A. van Rooij, F.J. Broekmans, G.J. Scheffer, C.W. Looman, J.D. Habbema, F.H. de Jong, B.J. Fauser, A.P. Themmen, E.R. te Velde, Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil. Steril. 83, 979–987 (2005)
Y. Fu, X. Zheng, L. Bao, K. Xu, X. Cheng, M. Sun, X. Xue, H. Chen, T. Yang, M. Zhang, Assessment of physiological factors for the establishment of serum insulin reference intervals in healthy Chinese Han adults: a community-based large cross-sectional study. Scand. J. Clin. Lab. Invest. 75, 319–326 (2015)
L. Cui, Y. Qin, X. Gao, J. Lu, L. Geng, L. Ding, Z. Qu, X. Zhang, Z.J. Chen, Antimüllerian hormone: correlation with age and androgenic and metabolic factors in women from birth to postmenopause. Fertil. Steril. 105, 481–485.e1 (2016)
L.G. Nardo, A.P. Yates, S.A. Roberts, P. Pemberton, I. Laing, The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome. Hum. Reprod. 24, 2917–2923 (2009)
C.Y. Andersen, K. Lossl, Increased intrafollicular androgen levels affect human granulosa cell secretion of anti-Müllerian hormone and inhibin-B. Fertil. Steril. 89, 1760–1765 (2008)
C. Bergh, B. Carlsson, J.H. Olsson, U. Selleskog, T. Hillensjö, Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil. Steril. 59, 323–331 (1993)
S. Ledoux, D.B. Campos, F.L. Lopes, M. Dobias-Goff, M.F. Palin, B.D. Murphy, Adiponectin induces periovulatory changes in ovarian follicular cells. Endocrinology 147, 5178–5186 (2006)
Y. Arita, S. Kihara, N. Ouchi, M. Takahashi, K. Maeda, J. Miyagawa, K. Hotta, I. Shimomura, T. Nakamura, K. Miyaoka, H. Kuriyama, M. Nishida, S. Yamashita, K. Okubo, K. Matsubara, M. Muraguchi, Y. Ohmoto, T. Funahashi, Y. Matsuzawa, Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. 1999. Biochem. Biophys. Res. Commun. 425, 560–564 (2012)
C. Chabrolle, L. Tosca, C. Ramé, P. Lecomte, D. Royère, J. Dupont, Adiponectin increases insulin-like growth factor I-induced progesterone and estradiol secretion in human granulosa cells. Fertil. Steril. 92, 1988–1996 (2009)
L. Cheng, H. Shi, Y. Jin, X. Li, J. Pan, Y. Lai, Y. Lin, Y. Jin, G. Roy, A. Zhao, F. Li, Adiponectin deficiency leads to female subfertility and ovarian dysfunctions in mice. Endocrinology 157, 4875–4887 (2016)
W.F. Zeng, Y. Li, C.S. Sheng, Q.F. Huang, Y.Y. Kang, L. Zhang, S. Wang, Y.B. Cheng, F.K. Li, J.G. Wang, Association of anthropometric and bioelectrical impedance analysis measures of adiposity with high molecular weight adiponectin concentration. PLoS One 11, e0156041 2016).
S. Kallio, J. Puurunen, A. Ruokonen, T. Vaskivuo, T. Piltonen, J.S. Tapanainen, Antimüllerian hormone levels decrease in women using combined contraception independently of administration route. Fertil. Steril. 99, 1305–1310 (2013)
J.G. Bentzen, J.L. Forman, A. Pinborg, Ø. Lidegaard, E.C. Larsen, L. Friis-Hansen, T.H. Johannsen, A. Nyboe. Andersen, Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception. Reprod. Biomed. Online 25, 612–619 (2012).
Acknowledgements
We are grateful to all of the staff working in the Maternal-foetal and Reproductive Medicine Department of Medlife
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
D.A. has received travel grants from Merck, Merck Sharp & Dohme and Ferring Pharmaceuticals. A.A. has received travel grants from Ferring Pharmaceuticals, Pfizer and a speaker honourarium from Sandoz Pharma Services.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Additional information
These authors contributed equally: Dragos Albu, Alice Albu
Rights and permissions
About this article
Cite this article
Albu, D., Albu, A. The relationship between anti-Müllerian hormone serum level and body mass index in a large cohort of infertile patients. Endocrine 63, 157–163 (2019). https://doi.org/10.1007/s12020-018-1756-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-018-1756-4